GE General Electric Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 90
Relative Strength: Rel. Strength: 46
Relative Valuation: Rel. Valuation: 28
Relative Profitability: Rel. Profitability: 74

EPS in 2026 (TTM): $8.72

Last Report Period Date: Sep 30, 2026

According to the most recent financial data from September 2026, the EPS for the trailing twelve months is $8.72. General Electric's EPS for 2025 amounted to $8.2, marking an increase from $6.04 in 2024. During the quarterly period ending on Sep 30, 2026, GE's EPS stood at $2.21.

GE earnings history

Historical annual and quarterly earnings per share (EPS) data for General Electric
EPS (TTM)
$8.72
EPS Growth YoY (Quarterly)
8.3%
EPS (Quarterly)
$2.21
EPS Growth (Quarterly)
-3.1%

General Electric had an annual EPS of $8.2, indicating an increase of 35.8% from $6.04 in 2024. The quarterly per-share earnings for the period ending Sep 30, 2026, was $2.21, indicating a 8.3% increase from the same quarter last year. GE's 12-month EPS stands at $8.72 as of September 2026. General Electric's annual EPS in 2024 stood at $6.04, a 28.4% decrease year-over-year.

GE EPS vs price chart

GE EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
8.3%
EPS growth YoY
35.8%
EPS growth 3Y avg
447.4%
EPS growth 5Y avg
12.1%

General Electric has registered an increase in EPS of 8.3% during the last 12 months (YoY, quarterly). In the last three years, GE recorded an average annual EPS growth rate of 447.4%. General Electric had an average annual EPS growth rate of 12.1% during the last 5 years.

GE Earnings Waterfall

Breakdown of revenue, profit and net income for General Electric

GE Earnings vs Peers

What are the earnings of GE compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
HON Honeywell International Inc 9.77 -15.4% 0.2% 1.7%
MDT Medtronic Plc 23.47 3.3% 9.8% 6.9%
MMM 3M Company 25.73 -20.2% -16% -8.5%
CAT Caterpillar Inc 29.55 -14.7% 14.1% 28%
GE General Electric Company 32.9 35.8% 447.4% 12.1%
TMO Thermo Fisher Scientific Inc 35.93 7.2% 0% 2%
DHR Danaher Corp 37.13 -4.9% -19.7% 0.4%
JNJ Johnson & Johnson 39.36 90.6% 17.7% 14.8%

All data is based on quarterly TTM periods, unless otherwise specified.